Efficiency of the Medidux Smartphone App for Post-Discharge Management in Patients Treated in Acute Admission Unit: A Randomized Controlled Trial

What this Trial Is About

This trial focuses on adults aged 18 and older admitted to Acute Admission Units (AAU) with non-urgent health complaints such as coughing, back pain, or abdominal discomfort. It aims to evaluate whether using the medidux132 smartphone app after discharge can reduce the rates of readmissions, emergency hospitalizations, and consultations with other medical providers within 7 days. The study compares this app-based monitoring approach with standard post-discharge care to understand its impact on patient outcomes. Participants are randomly assigned to either the intervention arm, where they use the medidux132 app to record symptoms and vital signs daily for 7 days after discharge, or the control arm, which receives usual care without the app. The app provides prompts and guidance to help users manage their symptoms and decide if further medical attention is needed. Follow-up assessments occur at 7 and 28 days post-discharge for all participants to evaluate symptom changes and healthcare use. During the study, participants will complete symptom tracking and vital sign monitoring through the app if in the intervention group, and both groups will attend follow-up consultations at day 7 and day 28. Researchers will measure outcomes including readmission rates, emergency hospitalizations, consultations with medical providers, symptom severity, and app usability. The primary outcome is the incidence of these events within 7 days after initial admission, with additional monitoring up to 28 days to assess longer-term effects.

Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU)